Epsilon M&A Deal Report - SDN (SDN Istituto di Ricerca Diagnostica e Nucleare)

Transaction Multiples for the Valuation of Private Companies

Labco > SDN (SDN Istituto di Ricerca Diagnostica e Nucleare)

Announced Date : 30 July 2014

Type : Exit ,Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Labco

Target: SDN (SDN Istituto di Ricerca Diagnostica e Nucleare)

Target Country: Italy

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1978, SDN SpA (SDN Istituto di Ricerca Diagnostica e Nucleare) is a provider of medi ...

No EMAT : 68804

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating **

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
14/11/2014	Recipharm	Lusomedicamenta-sociedade Tecnica Farmaceutica	Portugal	***
06/10/2014	Private Group led by Qualium Investissement	Aigle Capital (IMV Technologies)	France	**

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database